In RAW 264.7 cells and colon epithelial cells, HT-29 is found that caffeic acid acts as an anti-inflammatory modulator by suppressing the production of nitric oxide (NO), IL-1β, IL-6, IL-8, and TNF-α, suggesting their potential therapeutic in IBD 365. The gene discussed is IL1B; the disease is inflammatory bowel disease.